The EIC-ERC organised a workshop about Gene and Cell Therapy. The event was held online the 29th of June from 14:00 to 18:00 CET; even though the event was closed to the public, BOW participated on the activities and one of our partners, Antonella Bongiovanni, was a speaker in the “Thematic parallel sessions” about New vectors (viral and non-viral) for gene therapy. In this event the partners of BOW were able to highlight their knowledge on bio-nanotechnologies.
Agenda:
14:00 – 14:10: Welcome and Introduction
- Jean-Pierre Bourguignon (President ad interim, ERC Scientific Council)
- Mark Ferguson (Chair of the EIC Board)
14:10 – 14:50: Keynote speech
- Luigi Naldini (SR-Tiget, San Raffaele Telethon Institute for Gene Therapy, Italy)
14:50 – 15:10: Plenary session: Current global Cell and Gene Therapy landscape and trends
- Iordanis Arzimanoglou (Programme Manager EIC)
Break – 10 minutes
15:20 – Thematic parallel sessions
- Cell therapy, including stem cell therapy – Moderator: Margaret Buckingham (Institut Pasteur, France)
- Giulio Cossu (University of Manchester, UK)
- Michele De Luca (University of Modena and Reggio Emilia, Italy)
- Carl Figdor (Radboud University, The Netherlands)
- Magdalena Götz (Ludwig Maximilian University of Munich, Germany) Rogier Reijmers (Lumicks, The Netherlands)
- Jérémie Laurent (Astraveus, France)
- Disease modelling including 3D-bioprinted organs/organoids and other Regenerative Medicine novel approaches – Moderator: Geneviève Almouzni (Institut Curie, France)
-
- Hans Clevers (Hubrecht Institute for Developmental Biology and Stem Cell Research, The Netherlands)
- Prisca Liberali (Friedrich Miescher Institute for Biomedical Research, Switzerland)
- Christine Mummery (Leiden University, The Netherlands)
- Matthias Lütolf (EPFL, Switzerland)
- Øyvind Halaas (Norwegian University Science Technology, Norway)
- Francesca M. Spagnoli (Centre for Stem Cells and Regenerative Medicine, King’s College London, UK)
- New vectors (viral and non-viral) for gene therapy – Moderator: Marja Makarow (BioCenter, Finland)
- Stein Aerts (Flemish Institute for Biotechnology – KU Leuven, Belgium)
- Zsuzsanna Izsvák (Max Delbrück Centrum for Molecular Medicine, Germany)
- Federico Mingozzi (Association GENETHON, France & Spark Therapeutics, US)
- Seppo Ylä-Herttuala (University of Eastern Finland, Finland) Anna Pedrix Rosell (Sixfold Bioscience Ltd, The Imperial College White City Inc Innovation Hub, UK)
- Antonella Bongiovanni (CNR – Institute of Biomedical Research and Innovation in Palermo, Italy)
- Novel gene therapy approaches including RNA-based technologies – Moderator: NektariosTavernarakis (Foundation for Research and Technology, Greece)
- Roman Jerala (National Institute of Chemistry, Slovenia)
- Thorsten Stafforst (University of Tübingen, Germany)
- Molly Stevens (Imperial College London, UK)
- Pieter Vader (University of Utrecht, The Netherlands) Sven Panke (ETH, Switzerland)
- Stéphane Boissel (Sparingvision, France)
Break – 10 minutes
- 17:00 – 18:00: Roundtable discussion on transition from research to innovation in Cell and Gene Therapy with – Moderator: Brady Huggett (Senior Editor of Nature Biotechnology)
- Niccolo Bacchi (Novo Ventures, Denmark)
- Alessandra Biffi (University of Padua, Italy & Harvard Stem Cell Institute, US)
- Deniz Kirik (Lund University, Sweden)
- Jo Bury (Flemish Institute for Biotechnology, Belgium)
- Erik Gatenholm (Cellink, US, EU)
- Irene Norstedt (European Commission)
18:00 – 18:05: Conclusions